These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17569793)

  • 1. Structural basis of spirolactone recognition by the mineralocorticoid receptor.
    Huyet J; Pinon GM; Fay MR; Fagart J; Rafestin-Oblin ME
    Mol Pharmacol; 2007 Sep; 72(3):563-71. PubMed ID: 17569793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension.
    Pinon GM; Fagart J; Souque A; Auzou G; Vandewalle A; Rafestin-Oblin ME
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):181-8. PubMed ID: 15134816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Met852 residue is a key organizer of the ligand-binding cavity of the human mineralocorticoid receptor.
    Fagart J; Seguin C; Pinon GM; Rafestin-Oblin ME
    Mol Pharmacol; 2005 May; 67(5):1714-22. PubMed ID: 15716462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension.
    Fagart J; Huyet J; Pinon GM; Rochel M; Mayer C; Rafestin-Oblin ME
    Nat Struct Mol Biol; 2005 Jun; 12(6):554-5. PubMed ID: 15908963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinants of ligand binding to the mineralocorticoid receptor.
    Huyet J; Pinon GM; Fay MR; Rafestin-Oblin ME; Fagart J
    Mol Cell Endocrinol; 2012 Mar; 350(2):187-95. PubMed ID: 21820032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DFT-D investigation of the mechanisms for activation of the wild-type and S810L mutated mineralocorticoid receptor by steroid hormones.
    Riley KE; Hobza P
    J Phys Chem B; 2008 Mar; 112(10):3157-63. PubMed ID: 18284228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthetic androgen methyltrienolone (r1881) acts as a potent antagonist of the mineralocorticoid receptor.
    Takeda AN; Pinon GM; Bens M; Fagart J; Rafestin-Oblin ME; Vandewalle A
    Mol Pharmacol; 2007 Feb; 71(2):473-82. PubMed ID: 17105867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor.
    Li Y; Suino K; Daugherty J; Xu HE
    Mol Cell; 2005 Aug; 19(3):367-80. PubMed ID: 16061183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor.
    Bledsoe RK; Madauss KP; Holt JA; Apolito CJ; Lambert MH; Pearce KH; Stanley TB; Stewart EL; Trump RP; Willson TM; Williams SP
    J Biol Chem; 2005 Sep; 280(35):31283-93. PubMed ID: 15967794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corticosteroid hormones: mechanisms involved in the recognition of aldosterone by mineralocorticoid receptors].
    Hellal-Levy C; Fagart J; Souque A; Rafestin-Oblin ME
    J Soc Biol; 1999; 193(4-5):355-60. PubMed ID: 10689617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms.
    Hultman ML; Krasnoperova NV; Li S; Du S; Xia C; Dietz JD; Lala DS; Welsch DJ; Hu X
    Mol Endocrinol; 2005 Jun; 19(6):1460-73. PubMed ID: 15761029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology modelling of the ligand binding domain of mineralocorticoid receptor: close structural kinship with glucocorticoid receptor ligand binding domain and their similar binding mode with DOC (de-oxy corticosterone).
    Dey R; Roychowdhury P
    J Biomol Struct Dyn; 2002 Aug; 20(1):21-9. PubMed ID: 12144349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimineralocorticoid 11beta-substituted spirolactones exhibit androgen receptor agonistic activity: a structure function study.
    Nirdé P; Térouanne B; Gallais N; Sultan C; Auzou G
    Mol Pharmacol; 2001 May; 59(5):1307-13. PubMed ID: 11306716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Water Molecules on the Activating S810L Mutation of the Mineralocorticoid Receptor.
    Takedomi K; Ohta M; Ekimoto T; Ikeguchi M
    J Chem Inf Model; 2021 Jul; 61(7):3583-3592. PubMed ID: 34228431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel missense mutation, F826Y, in the mineralocorticoid receptor gene in Japanese hypertensives: its implications for clinical phenotypes.
    Kamide K; Yang J; Kokubo Y; Takiuchi S; Miwa Y; Horio T; Tanaka C; Banno M; Nagura J; Okayama A; Tomoike H; Kawano Y; Miyata T
    Hypertens Res; 2005 Sep; 28(9):703-9. PubMed ID: 16419642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins.
    Petit-Topin I; Turque N; Fagart J; Fay M; Ulmann A; Gainer E; Rafestin-Oblin ME
    Mol Pharmacol; 2009 Jun; 75(6):1317-24. PubMed ID: 19289570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors.
    Petit-Topin I; Fay M; Resche-Rigon M; Ulmann A; Gainer E; Rafestin-Oblin ME; Fagart J
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():427-35. PubMed ID: 25204619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards selectively modulating mineralocorticoid receptor function: lessons from other systems.
    Baxter JD; Funder JW; Apriletti JW; Webb P
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):151-65. PubMed ID: 15134814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.
    Amazit L; Le Billan F; Kolkhof P; Lamribet K; Viengchareun S; Fay MR; Khan JA; Hillisch A; Lombès M; Rafestin-Oblin ME; Fagart J
    J Biol Chem; 2015 Sep; 290(36):21876-89. PubMed ID: 26203193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.